Virtus Pharmaceuticals Recalls Virt-Select Prenatal Softgels Due to GMP Deviations
Virtus Pharmaceuticals is recalling Virt-Select Prenatal/Postnatal Softgels because the active ingredient manufacturer is on an FDA Import Alert for cGMP deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which typically corresponds to a severity score of 1 or 2. Given the specific mention of cGMP deviations and an Import Alert for the API manufacturer, a score of 2 (Moderate) is appropriate as it reflects a voluntary precautionary measure for a low-risk contamination or manufacturing issue.
Plain-English summary
Virtus Pharmaceuticals OPCO II L is recalling Virt-Select Prenatal/Postnatal Softgels, a prescription multivitamin/mineral dietary supplement with fish-based DHA. The product is packaged in 30-count bottles and is identified by NDC 76439-249-30. The recall involves 9,795 bottles from Lot # 21511153, which has an expiration date of 10/30/2017.
The recall was initiated due to Current Good Manufacturing Practice (cGMP) deviations. Specifically, the manufacturer of the Active Pharmaceutical Ingredient (API) is currently on an FDA Import Alert. The product was distributed nationwide.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for guidance on disposal or replacement. This recall is classified as Class III by the FDA, indicating that use of or exposure to the product is not likely to cause adverse health consequences.
The recalled product
- Product
- Virt-Select Prenatal/Postnatal Softgels, Prescription Multivitamin/Mineral Dietary Supplement with Fish-Based DHA , packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-249-30
- Manufacturer
- VIRTUS PHARMACEUTICALS OPCO II L
- Category
- Drug — Dietary Supplement
- Affected units
- 9,795
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lots #: 21511153 Exp. date 10/30/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by VIRTUS PHARMACEUTICALS OPCO II L under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · VIRTUS PHARMACEUTICALS OPCO II L
See all →- LowVirtus Pharmaceuticals Recalls Extra-Virt Plus DHA Prenatal Softgels
FDA (Drugs) · 2017-01-04
- LowVirt-Advance Prenatal Softgels Recalled Due to API Manufacturer Import Alert
FDA (Drugs) · 2017-01-04
- LowVirtPrex Prenatal Tablets Recalled Due to API Manufacturer Import Alert
FDA (Drugs) · 2017-01-04
- SevereVirtus Recalls Hyoscyamine Sulfate Tablets Due to Content Uniformity Failures
FDA (Drugs) · 2016-12-28
- SevereVirtus Recalls Hyoscyamine Sulfate Tablets Due to Potency Failures
FDA (Drugs) · 2016-12-28
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14